Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2015-09-01 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75011), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE CENTRALE DU XI EME : revenue, balance sheet and financial ratios
SELAS PHARMACIE CENTRALE DU XI EME is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75011),
this company of category PME
shows in 2023 a net income positive of 88 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE CENTRALE DU XI EME (SIREN 813298411)
Indicator
2023
Revenue
N/C
Net income
88 199 €
EBITDA
N/C
Net margin
N/C
Revenue and income statement
In 2023, SELAS PHARMACIE CENTRALE DU XI EME generates positive net income of 88 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
88 199 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 86%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 45%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
86.101%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
44.795%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELAS PHARMACIE CENTRALE DU XI EME
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2023
Debt ratio
86.101
Financial autonomy
44.795
Repayment capacity
None
Cash flow / Revenue
None%
Sector positioning
Debt ratio
86.12023
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average
In 2023, the debt ratio of SELAS PHARMACIE CENTRALE ... (86.10) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
44.8%2023
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of SELAS PHARMACIE CENTRALE ... (44.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 103.85. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
103.854
Liquidity indicators evolution SELAS PHARMACIE CENTRALE DU XI EME
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2023
Liquidity ratio
103.854
Interest coverage
None
Sector positioning
Liquidity ratio
103.852023
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Watch
In 2023, the liquidity ratio of SELAS PHARMACIE CENTRALE ... (103.85) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of SELAS PHARMACIE CENTRALE DU XI EME in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SELAS PHARMACIE CENTRALE DU XI EME is estimated at
1 040 701 €
(range 632 900€ - 1 462 993€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
632k€1040k€1462k€
1 040 701 €Range: 632 900€ - 1 462 993€
NAF 5 année 2023
Valuation method used
Net Income Multiple
88 199 €
×
11.8x
=1 040 702 €
Range: 632 901€ - 1 462 993€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE CENTRALE DU XI EME with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE CENTRALE DU XI EME
What is the revenue of SELAS PHARMACIE CENTRALE DU XI EME ?
The revenue of SELAS PHARMACIE CENTRALE DU XI EME is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS PHARMACIE CENTRALE DU XI EME profitable?
Yes, SELAS PHARMACIE CENTRALE DU XI EME generated a net profit of 88 k€ in 2023.
Where is the headquarters of SELAS PHARMACIE CENTRALE DU XI EME ?
The headquarters of SELAS PHARMACIE CENTRALE DU XI EME is located in PARIS (75011), in the department Paris.
Where to find the tax return of SELAS PHARMACIE CENTRALE DU XI EME ?
The tax return of SELAS PHARMACIE CENTRALE DU XI EME is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE CENTRALE DU XI EME operate?
SELAS PHARMACIE CENTRALE DU XI EME operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart